Back

Elevated Lp(a) in primary and secondary prevention in Greece: prevalence and clinical relevance

31 August 2025 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Lipids (2) Lipids ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr George Zervas

National & Kapodistrian University of Athens Medical School, Athens (Greece)

3 More presentations in this session

Presentation thumbnail
Effect of hospital Intensive lipid-lowering protocol on low density lipoprotein cholesterol control and clinical outcomes in patients with acute myocardial infarction
Doctor S. Fujioka (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Design and initial results of the Canadian lipoprotein(a) registry
Associate Professor L. Brunham (Vancouver, CA)
Abstract Slides Video
Presentation thumbnail
Marked variability in reporting of low-density lipoprotein cholesterol values: a national review of pathology providers in Australia
Doctor R. Ma (Melbourne, AU)
Abstract Slides Video

Access the full session

Session thumbnail
Lipids (2)

The Event

Event poster

ESC Congress 2025

31 August 2025 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Lipoprotein(a) measurements identify patients with elevated likelihood of obstructive coronary artery disease despite very low or low clinical likelihood
thumbnail
Congress Presentation
Ethnic differences in lipoprotein(a)-associated ASCVD risk and the impact of standard modifiable cardiovascular risk factors: insights from the multi-ethnic HELIUS cohort
thumbnail
Congress Presentation
Comparison of cardiovascular disease risk assessment tools in primary prevention patients with raised lipoprotein(a)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources